Table of Content

1 Cellular and Gene Therapy Product Market Overview
1.1 Cellular and Gene Therapy Product Product Overview
1.2 Cellular and Gene Therapy Product Market Segment by Type
1.2.1 Cellular Immunotherapies
1.2.2 Cancer Vaccines
1.2.3 Autologous and Allogeneic Cells
1.3 Global Cellular and Gene Therapy Product Market Size by Type
1.3.1 Global Cellular and Gene Therapy Product Market Size Overview by Type (2018-2033)
1.3.2 Global Cellular and Gene Therapy Product Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cellular and Gene Therapy Product Forecasted Market Size by Type (2024-2033)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cellular and Gene Therapy Product Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cellular and Gene Therapy Product Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cellular and Gene Therapy Product Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cellular and Gene Therapy Product Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cellular and Gene Therapy Product Sales Breakdown by Type (2018-2023)
2 Global Cellular and Gene Therapy Product Market Competition by Company
2.1 Global Top Players by Cellular and Gene Therapy Product Sales (2018-2023)
2.2 Global Top Players by Cellular and Gene Therapy Product Revenue (2018-2023)
2.3 Global Top Players by Cellular and Gene Therapy Product Price (2018-2023)
2.4 Global Top Manufacturers Cellular and Gene Therapy Product Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cellular and Gene Therapy Product Market Competitive Situation and Trends
2.5.1 Cellular and Gene Therapy Product Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cellular and Gene Therapy Product Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cellular and Gene Therapy Product as of 2022)
2.7 Date of Key Manufacturers Enter into Cellular and Gene Therapy Product Market
2.8 Key Manufacturers Cellular and Gene Therapy Product Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cellular and Gene Therapy Product Status and Outlook by Region
3.1 Global Cellular and Gene Therapy Product Market Size and CAGR by Region: 2018 VS 2022 VS 2033
3.2 Global Cellular and Gene Therapy Product Historic Market Size by Region
3.2.1 Global Cellular and Gene Therapy Product Sales in Volume by Region (2018-2023)
3.2.2 Global Cellular and Gene Therapy Product Sales in Value by Region (2018-2023)
3.2.3 Global Cellular and Gene Therapy Product Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cellular and Gene Therapy Product Forecasted Market Size by Region
3.3.1 Global Cellular and Gene Therapy Product Sales in Volume by Region (2024-2033)
3.3.2 Global Cellular and Gene Therapy Product Sales in Value by Region (2024-2033)
3.3.3 Global Cellular and Gene Therapy Product Sales (Volume & Value), Price and Gross Margin (2024-2033)
4 Global Cellular and Gene Therapy Product by Application
4.1 Cellular and Gene Therapy Product Market Segment by Application
4.1.1 Blood Cancer
4.1.2 Prostate Cancer
4.1.3 Skin Cancer
4.1.4 Other
4.2 Global Cellular and Gene Therapy Product Market Size by Application
4.2.1 Global Cellular and Gene Therapy Product Market Size Overview by Application (2018-2033)
4.2.2 Global Cellular and Gene Therapy Product Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cellular and Gene Therapy Product Forecasted Market Size by Application (2024-2033)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cellular and Gene Therapy Product Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cellular and Gene Therapy Product Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cellular and Gene Therapy Product Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cellular and Gene Therapy Product Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cellular and Gene Therapy Product Sales Breakdown by Application (2018-2023)
5 North America Cellular and Gene Therapy Product by Country
5.1 North America Cellular and Gene Therapy Product Historic Market Size by Country
5.1.1 North America Cellular and Gene Therapy Product Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
5.1.2 North America Cellular and Gene Therapy Product Sales in Volume by Country (2018-2023)
5.1.3 North America Cellular and Gene Therapy Product Sales in Value by Country (2018-2023)
5.2 North America Cellular and Gene Therapy Product Forecasted Market Size by Country
5.2.1 North America Cellular and Gene Therapy Product Sales in Volume by Country (2024-2033)
5.2.2 North America Cellular and Gene Therapy Product Sales in Value by Country (2024-2033)
6 Europe Cellular and Gene Therapy Product by Country
6.1 Europe Cellular and Gene Therapy Product Historic Market Size by Country
6.1.1 Europe Cellular and Gene Therapy Product Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
6.1.2 Europe Cellular and Gene Therapy Product Sales in Volume by Country (2018-2023)
6.1.3 Europe Cellular and Gene Therapy Product Sales in Value by Country (2018-2023)
6.2 Europe Cellular and Gene Therapy Product Forecasted Market Size by Country
6.2.1 Europe Cellular and Gene Therapy Product Sales in Volume by Country (2024-2033)
6.2.2 Europe Cellular and Gene Therapy Product Sales in Value by Country (2024-2033)
7 Asia-Pacific Cellular and Gene Therapy Product by Region
7.1 Asia-Pacific Cellular and Gene Therapy Product Historic Market Size by Region
7.1.1 Asia-Pacific Cellular and Gene Therapy Product Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2033
7.1.2 Asia-Pacific Cellular and Gene Therapy Product Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cellular and Gene Therapy Product Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cellular and Gene Therapy Product Forecasted Market Size by Region
7.2.1 Asia-Pacific Cellular and Gene Therapy Product Sales in Volume by Region (2024-2033)
7.2.2 Asia-Pacific Cellular and Gene Therapy Product Sales in Value by Region (2024-2033)
8 Latin America Cellular and Gene Therapy Product by Country
8.1 Latin America Cellular and Gene Therapy Product Historic Market Size by Country
8.1.1 Latin America Cellular and Gene Therapy Product Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
8.1.2 Latin America Cellular and Gene Therapy Product Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cellular and Gene Therapy Product Sales in Value by Country (2018-2023)
8.2 Latin America Cellular and Gene Therapy Product Forecasted Market Size by Country
8.2.1 Latin America Cellular and Gene Therapy Product Sales in Volume by Country (2024-2033)
8.2.2 Latin America Cellular and Gene Therapy Product Sales in Value by Country (2024-2033)
9 Middle East and Africa Cellular and Gene Therapy Product by Country
9.1 Middle East and Africa Cellular and Gene Therapy Product Historic Market Size by Country
9.1.1 Middle East and Africa Cellular and Gene Therapy Product Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2033
9.1.2 Middle East and Africa Cellular and Gene Therapy Product Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cellular and Gene Therapy Product Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cellular and Gene Therapy Product Forecasted Market Size by Country
9.2.1 Middle East and Africa Cellular and Gene Therapy Product Sales in Volume by Country (2024-2033)
9.2.2 Middle East and Africa Cellular and Gene Therapy Product Sales in Value by Country (2024-2033)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Cellular and Gene Therapy Product Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 New York Blood Center
10.2.1 New York Blood Center Company Information
10.2.2 New York Blood Center Introduction and Business Overview
10.2.3 New York Blood Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.2.4 New York Blood Center Cellular and Gene Therapy Product Products Offered
10.2.5 New York Blood Center Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Johnson & Johnson Cellular and Gene Therapy Product Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Cleveland Cord Blood Center
10.4.1 Cleveland Cord Blood Center Company Information
10.4.2 Cleveland Cord Blood Center Introduction and Business Overview
10.4.3 Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cleveland Cord Blood Center Cellular and Gene Therapy Product Products Offered
10.4.5 Cleveland Cord Blood Center Recent Development
10.5 Organogenesis
10.5.1 Organogenesis Company Information
10.5.2 Organogenesis Introduction and Business Overview
10.5.3 Organogenesis Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Organogenesis Cellular and Gene Therapy Product Products Offered
10.5.5 Organogenesis Recent Development
10.6 Duke University School of Medicine
10.6.1 Duke University School of Medicine Company Information
10.6.2 Duke University School of Medicine Introduction and Business Overview
10.6.3 Duke University School of Medicine Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Duke University School of Medicine Cellular and Gene Therapy Product Products Offered
10.6.5 Duke University School of Medicine Recent Development
10.7 Colorado Cord Blood Banking
10.7.1 Colorado Cord Blood Banking Company Information
10.7.2 Colorado Cord Blood Banking Introduction and Business Overview
10.7.3 Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Colorado Cord Blood Banking Cellular and Gene Therapy Product Products Offered
10.7.5 Colorado Cord Blood Banking Recent Development
10.8 MD Anderson Cancer Center
10.8.1 MD Anderson Cancer Center Company Information
10.8.2 MD Anderson Cancer Center Introduction and Business Overview
10.8.3 MD Anderson Cancer Center Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.8.4 MD Anderson Cancer Center Cellular and Gene Therapy Product Products Offered
10.8.5 MD Anderson Cancer Center Recent Development
10.9 LifeSouth Community Blood Centers
10.9.1 LifeSouth Community Blood Centers Company Information
10.9.2 LifeSouth Community Blood Centers Introduction and Business Overview
10.9.3 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.9.4 LifeSouth Community Blood Centers Cellular and Gene Therapy Product Products Offered
10.9.5 LifeSouth Community Blood Centers Recent Development
10.10 Bloodworks Northwest
10.10.1 Bloodworks Northwest Company Information
10.10.2 Bloodworks Northwest Introduction and Business Overview
10.10.3 Bloodworks Northwest Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bloodworks Northwest Cellular and Gene Therapy Product Products Offered
10.10.5 Bloodworks Northwest Recent Development
10.11 Amgen
10.11.1 Amgen Company Information
10.11.2 Amgen Introduction and Business Overview
10.11.3 Amgen Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Amgen Cellular and Gene Therapy Product Products Offered
10.11.5 Amgen Recent Development
10.12 Novartis Pharmaceuticals
10.12.1 Novartis Pharmaceuticals Company Information
10.12.2 Novartis Pharmaceuticals Introduction and Business Overview
10.12.3 Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Novartis Pharmaceuticals Cellular and Gene Therapy Product Products Offered
10.12.5 Novartis Pharmaceuticals Recent Development
10.13 Castle Creek Biosciences
10.13.1 Castle Creek Biosciences Company Information
10.13.2 Castle Creek Biosciences Introduction and Business Overview
10.13.3 Castle Creek Biosciences Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Castle Creek Biosciences Cellular and Gene Therapy Product Products Offered
10.13.5 Castle Creek Biosciences Recent Development
10.14 Spark Therapeutics
10.14.1 Spark Therapeutics Company Information
10.14.2 Spark Therapeutics Introduction and Business Overview
10.14.3 Spark Therapeutics Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Spark Therapeutics Cellular and Gene Therapy Product Products Offered
10.14.5 Spark Therapeutics Recent Development
10.15 Vericel
10.15.1 Vericel Company Information
10.15.2 Vericel Introduction and Business Overview
10.15.3 Vericel Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Vericel Cellular and Gene Therapy Product Products Offered
10.15.5 Vericel Recent Development
10.16 Dendreon Pharmaceuticals
10.16.1 Dendreon Pharmaceuticals Company Information
10.16.2 Dendreon Pharmaceuticals Introduction and Business Overview
10.16.3 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Dendreon Pharmaceuticals Cellular and Gene Therapy Product Products Offered
10.16.5 Dendreon Pharmaceuticals Recent Development
10.17 Enzyvant Therapeutics GmbH
10.17.1 Enzyvant Therapeutics GmbH Company Information
10.17.2 Enzyvant Therapeutics GmbH Introduction and Business Overview
10.17.3 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Products Offered
10.17.5 Enzyvant Therapeutics GmbH Recent Development
10.18 Mallinckrodt
10.18.1 Mallinckrodt Company Information
10.18.2 Mallinckrodt Introduction and Business Overview
10.18.3 Mallinckrodt Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Mallinckrodt Cellular and Gene Therapy Product Products Offered
10.18.5 Mallinckrodt Recent Development
10.19 Gilead Sciences
10.19.1 Gilead Sciences Company Information
10.19.2 Gilead Sciences Introduction and Business Overview
10.19.3 Gilead Sciences Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Gilead Sciences Cellular and Gene Therapy Product Products Offered
10.19.5 Gilead Sciences Recent Development
10.20 bluebird bio
10.20.1 bluebird bio Company Information
10.20.2 bluebird bio Introduction and Business Overview
10.20.3 bluebird bio Cellular and Gene Therapy Product Sales, Revenue and Gross Margin (2018-2023)
10.20.4 bluebird bio Cellular and Gene Therapy Product Products Offered
10.20.5 bluebird bio Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cellular and Gene Therapy Product Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cellular and Gene Therapy Product Industrial Chain Analysis
11.4 Cellular and Gene Therapy Product Market Dynamics
11.4.1 Cellular and Gene Therapy Product Industry Trends
11.4.2 Cellular and Gene Therapy Product Market Drivers
11.4.3 Cellular and Gene Therapy Product Market Challenges
11.4.4 Cellular and Gene Therapy Product Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cellular and Gene Therapy Product Distributors
12.3 Cellular and Gene Therapy Product Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Cellular Immunotherapies
Table 2. Major Company of Cancer Vaccines
Table 3. Major Company of Autologous and Allogeneic Cells
Table 4. Global Cellular and Gene Therapy Product Sales by Type 2018 VS 2022 VS 2033 (US$ Million)
Table 5. Global Cellular and Gene Therapy Product Sales by Type (2018-2023) & (K Units)
Table 6. Global Cellular and Gene Therapy Product Sales Market Share in Volume by Type (2018-2023)
Table 7. Global Cellular and Gene Therapy Product Sales by Type (2018-2023) & (US& Million)
Table 8. Global Cellular and Gene Therapy Product Market Share in Value by Type (2018-2023)
Table 9. Global Cellular and Gene Therapy Product Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Cellular and Gene Therapy Product Sales by Type (2024-2033) & (K Units)
Table 11. Global Cellular and Gene Therapy Product Sales Market Share in Volume by Type (2024-2033)
Table 12. Global Cellular and Gene Therapy Product Sales by Type (2024-2033) & (US$ Million)
Table 13. Global Cellular and Gene Therapy Product Sales Market Share in Value by Type (2024-2033)
Table 14. Global Cellular and Gene Therapy Product Price by Type (2024-2033) & (US$/Unit)
Table 15. North America Cellular and Gene Therapy Product Sales by Type (2018-2023) & (K Units)
Table 16. North America Cellular and Gene Therapy Product Sales by Type (2018-2023) & (US$ Million)
Table 17. Europe Cellular and Gene Therapy Product Sales (K Units) by Type (2018-2023)
Table 18. Europe Cellular and Gene Therapy Product Sales by Type (2018-2023) & (US$ Million)
Table 19. Asia-Pacific Cellular and Gene Therapy Product Sales (K Units) by Type (2018-2023)
Table 20. Asia-Pacific Cellular and Gene Therapy Product Sales by Type (2018-2023) & (US$ Million)
Table 21. Latin America Cellular and Gene Therapy Product Sales (K Units) by Type (2018-2023)
Table 22. Latin America Cellular and Gene Therapy Product Sales by Type (2018-2023) & (US$ Million)
Table 23. Middle East and Africa Cellular and Gene Therapy Product Sales (K Units) by Type (2018-2023)
Table 24. Middle East and Africa Cellular and Gene Therapy Product Sales by Type (2018-2023) & (US$ Million)
Table 25. Global Cellular and Gene Therapy Product Sales by Company (2018-2023) & (K Units)
Table 26. Global Cellular and Gene Therapy Product Sales Share by Company (2018-2023)
Table 27. Global Cellular and Gene Therapy Product Revenue by Company (2018-2023) & (US$ Million)
Table 28. Global Cellular and Gene Therapy Product Revenue Share by Company (2018-2023)
Table 29. Global Market Cellular and Gene Therapy Product Price by Company (2018-2023) & (US$/Unit)
Table 30. Global Cellular and Gene Therapy Product Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Cellular and Gene Therapy Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cellular and Gene Therapy Product as of 2022)
Table 33. Date of Key Manufacturers Enter into Cellular and Gene Therapy Product Market
Table 34. Key Manufacturers Cellular and Gene Therapy Product Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Cellular and Gene Therapy Product Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2033
Table 37. Global Cellular and Gene Therapy Product Sales by Region (2018-2023) & (K Units)
Table 38. Global Cellular and Gene Therapy Product Sales Market Share in Volume by Region (2018-2023)
Table 39. Global Cellular and Gene Therapy Product Sales by Region (2018-2023) & (US$ Million)
Table 40. Global Cellular and Gene Therapy Product Sales Market Share in Value by Region (2018-2023)
Table 41. Global Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 42. Global Cellular and Gene Therapy Product Sales by Region (2024-2033) & (K Units)
Table 43. Global Cellular and Gene Therapy Product Sales Market Share in Volume by Region (2024-2033)
Table 44. Global Cellular and Gene Therapy Product Sales by Region (2024-2033) & (US$ Million)
Table 45. Global Cellular and Gene Therapy Product Sales Market Share in Value by Region (2024-2033)
Table 46. Global Cellular and Gene Therapy Product Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2033)
Table 47. Global Cellular and Gene Therapy Product Sales by Application: 2018 VS 2022 VS 2033 (US$ Million)
Table 48. Global Cellular and Gene Therapy Product Sales by Application (2018-2023) & (K Units)
Table 49. Global Cellular and Gene Therapy Product Sales Market Share in Volume by Application (2018-2023)
Table 50. Global Cellular and Gene Therapy Product Sales by Application (2018-2023) & (US$ Million)
Table 51. Global Cellular and Gene Therapy Product Sales Market Share in Value by Application (2018-2023)
Table 52. Global Cellular and Gene Therapy Product Price by Application (2018-2023) & (US$/Unit)
Table 53. Global Cellular and Gene Therapy Product Sales by Application (2024-2033) & (K Units)
Table 54. Global Cellular and Gene Therapy Product Sales Market Share in Volume by Application (2024-2033)
Table 55. Global Cellular and Gene Therapy Product Sales by Application (2024-2033) & (US$ Million)
Table 56. Global Cellular and Gene Therapy Product Sales Market Share in Value by Application (2024-2033)
Table 57. Global Cellular and Gene Therapy Product Price by Application (2024-2033) & (US$/Unit)
Table 58. North America Cellular and Gene Therapy Product Sales by Application (2018-2023) (K Units)
Table 59. North America Cellular and Gene Therapy Product Sales by Application (2018-2023) & (US$ Million)
Table 60. Europe Cellular and Gene Therapy Product Sales by Application (2018-2023) (K Units)
Table 61. Europe Cellular and Gene Therapy Product Sales by Application (2018-2023) & (US$ Million)
Table 62. Asia-Pacific Cellular and Gene Therapy Product Sales by Application (2018-2023) (K Units)
Table 63. Asia-Pacific Cellular and Gene Therapy Product Sales by Application (2018-2023) & (US$ Million)
Table 64. Latin America Cellular and Gene Therapy Product Sales by Application (2018-2023) (K Units)
Table 65. Latin America Cellular and Gene Therapy Product Sales by Application (2018-2023) & (US$ Million)
Table 66. Middle East and Africa Cellular and Gene Therapy Product Sales by Application (2018-2023) (K Units)
Table 67. Middle East and Africa Cellular and Gene Therapy Product Sales by Application (2018-2023) & (US$ Million)
Table 68. North America Cellular and Gene Therapy Product Sales by Country (2018-2023) & (K Units)
Table 69. North America Cellular and Gene Therapy Product Sales Market Share in Volume by Country (2018-2023)
Table 70. North America Cellular and Gene Therapy Product Sales by Country (2018-2023) & (US$ Million)
Table 71. North America Cellular and Gene Therapy Product Sales Market Share in Value by Country (2018-2023)
Table 72. North America Cellular and Gene Therapy Product Sales by Country (2024-2033) & (K Units)
Table 73. North America Cellular and Gene Therapy Product Sales Market Share in Volume by Country (2024-2033)
Table 74. North America Cellular and Gene Therapy Product Sales by Country (2024-2033) & (US$ Million)
Table 75. North America Cellular and Gene Therapy Product Sales Market Share in Value by Country (2024-2033)
Table 76. Europe Cellular and Gene Therapy Product Sales by Country (2018-2023) & (K Units)
Table 77. Europe Cellular and Gene Therapy Product Sales Market Share in Volume by Country (2018-2023)
Table 78. Europe Cellular and Gene Therapy Product Sales by Country (2018-2023) & (US$ Million)
Table 79. Europe Cellular and Gene Therapy Product Sales Market Share in Value by Country (2018-2023)
Table 80. Europe Cellular and Gene Therapy Product Sales by Country (2024-2033) & (K Units)
Table 81. Europe Cellular and Gene Therapy Product Sales Market Share in Volume by Country (2024-2033)
Table 82. Europe Cellular and Gene Therapy Product Sales by Country (2024-2033) & (US$ Million)
Table 83. Europe Cellular and Gene Therapy Product Sales Market Share in Value by Country (2024-2033)
Table 84. Asia-Pacific Cellular and Gene Therapy Product Sales by Region (2018-2023) & (K Units)
Table 85. Asia-Pacific Cellular and Gene Therapy Product Sales Market Share in Volume by Region (2018-2023)
Table 86. Asia-Pacific Cellular and Gene Therapy Product Sales by Region (2018-2023) & (US$ Million)
Table 87. Asia-Pacific Cellular and Gene Therapy Product Sales Market Share in Value by Region (2018-2023)
Table 88. Asia-Pacific Cellular and Gene Therapy Product Sales by Region (2024-2033) & (K Units)
Table 89. Asia-Pacific Cellular and Gene Therapy Product Sales Market Share in Volume by Region (2024-2033)
Table 90. Asia-Pacific Cellular and Gene Therapy Product Sales by Region (2024-2033) & (US$ Million)
Table 91. Asia-Pacific Cellular and Gene Therapy Product Sales Market Share in Value by Region (2024-2033)
Table 92. Latin America Cellular and Gene Therapy Product Sales by Country (2018-2023) & (K Units)
Table 93. Latin America Cellular and Gene Therapy Product Sales Market Share in Volume by Country (2018-2023)
Table 94. Latin America Cellular and Gene Therapy Product Sales by Country (2018-2023) & (US$ Million)
Table 95. Latin America Cellular and Gene Therapy Product Sales Market Share in Value by Country (2018-2023)
Table 96. Latin America Cellular and Gene Therapy Product Sales by Country (2024-2033) & (K Units)
Table 97. Latin America Cellular and Gene Therapy Product Sales Market Share in Volume by Country (2024-2033)
Table 98. Latin America Cellular and Gene Therapy Product Sales by Country (2024-2033) & (US$ Million)
Table 99. Latin America Cellular and Gene Therapy Product Sales Market Share in Value by Country (2024-2033)
Table 100. Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2018-2023) & (K Units)
Table 101. Middle East and Africa Cellular and Gene Therapy Product Sales Market Share in Volume by Country (2018-2023)
Table 102. Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2018-2023) & (US$ Million)
Table 103. Middle East and Africa Cellular and Gene Therapy Product Sales Market Share in Value by Country (2018-2023)
Table 104. Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2024-2033) & (K Units)
Table 105. Middle East and Africa Cellular and Gene Therapy Product Sales Market Share in Volume by Country (2024-2033)
Table 106. Middle East and Africa Cellular and Gene Therapy Product Sales by Country (2024-2033) & (US$ Million)
Table 107. Middle East and Africa Cellular and Gene Therapy Product Sales Market Share in Value by Country (2024-2033)
Table 108. Bristol-Myers Squibb Company Information
Table 109. Bristol-Myers Squibb Introduction and Business Overview
Table 110. Bristol-Myers Squibb Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Bristol-Myers Squibb Cellular and Gene Therapy Product Product
Table 112. Bristol-Myers Squibb Recent Development
Table 113. New York Blood Center Company Information
Table 114. New York Blood Center Introduction and Business Overview
Table 115. New York Blood Center Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. New York Blood Center Cellular and Gene Therapy Product Product
Table 117. New York Blood Center Recent Development
Table 118. Johnson & Johnson Company Information
Table 119. Johnson & Johnson Introduction and Business Overview
Table 120. Johnson & Johnson Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Johnson & Johnson Cellular and Gene Therapy Product Product
Table 122. Johnson & Johnson Recent Development
Table 123. Cleveland Cord Blood Center Company Information
Table 124. Cleveland Cord Blood Center Introduction and Business Overview
Table 125. Cleveland Cord Blood Center Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Cleveland Cord Blood Center Cellular and Gene Therapy Product Product
Table 127. Cleveland Cord Blood Center Recent Development
Table 128. Organogenesis Company Information
Table 129. Organogenesis Introduction and Business Overview
Table 130. Organogenesis Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Organogenesis Cellular and Gene Therapy Product Product
Table 132. Organogenesis Recent Development
Table 133. Duke University School of Medicine Company Information
Table 134. Duke University School of Medicine Introduction and Business Overview
Table 135. Duke University School of Medicine Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Duke University School of Medicine Cellular and Gene Therapy Product Product
Table 137. Duke University School of Medicine Recent Development
Table 138. Colorado Cord Blood Banking Company Information
Table 139. Colorado Cord Blood Banking Introduction and Business Overview
Table 140. Colorado Cord Blood Banking Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Colorado Cord Blood Banking Cellular and Gene Therapy Product Product
Table 142. Colorado Cord Blood Banking Recent Development
Table 143. MD Anderson Cancer Center Company Information
Table 144. MD Anderson Cancer Center Introduction and Business Overview
Table 145. MD Anderson Cancer Center Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. MD Anderson Cancer Center Cellular and Gene Therapy Product Product
Table 147. MD Anderson Cancer Center Recent Development
Table 148. LifeSouth Community Blood Centers Company Information
Table 149. LifeSouth Community Blood Centers Introduction and Business Overview
Table 150. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. LifeSouth Community Blood Centers Cellular and Gene Therapy Product Product
Table 152. LifeSouth Community Blood Centers Recent Development
Table 153. Bloodworks Northwest Company Information
Table 154. Bloodworks Northwest Introduction and Business Overview
Table 155. Bloodworks Northwest Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Bloodworks Northwest Cellular and Gene Therapy Product Product
Table 157. Bloodworks Northwest Recent Development
Table 158. Amgen Company Information
Table 159. Amgen Introduction and Business Overview
Table 160. Amgen Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. Amgen Cellular and Gene Therapy Product Product
Table 162. Amgen Recent Development
Table 163. Novartis Pharmaceuticals Company Information
Table 164. Novartis Pharmaceuticals Introduction and Business Overview
Table 165. Novartis Pharmaceuticals Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 166. Novartis Pharmaceuticals Cellular and Gene Therapy Product Product
Table 167. Novartis Pharmaceuticals Recent Development
Table 168. Castle Creek Biosciences Company Information
Table 169. Castle Creek Biosciences Introduction and Business Overview
Table 170. Castle Creek Biosciences Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 171. Castle Creek Biosciences Cellular and Gene Therapy Product Product
Table 172. Castle Creek Biosciences Recent Development
Table 173. Spark Therapeutics Company Information
Table 174. Spark Therapeutics Introduction and Business Overview
Table 175. Spark Therapeutics Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 176. Spark Therapeutics Cellular and Gene Therapy Product Product
Table 177. Spark Therapeutics Recent Development
Table 178. Vericel Company Information
Table 179. Vericel Introduction and Business Overview
Table 180. Vericel Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 181. Vericel Cellular and Gene Therapy Product Product
Table 182. Vericel Recent Development
Table 183. Dendreon Pharmaceuticals Company Information
Table 184. Dendreon Pharmaceuticals Introduction and Business Overview
Table 185. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 186. Dendreon Pharmaceuticals Cellular and Gene Therapy Product Product
Table 187. Dendreon Pharmaceuticals Recent Development
Table 188. Enzyvant Therapeutics GmbH Company Information
Table 189. Enzyvant Therapeutics GmbH Introduction and Business Overview
Table 190. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 191. Enzyvant Therapeutics GmbH Cellular and Gene Therapy Product Product
Table 192. Enzyvant Therapeutics GmbH Recent Development
Table 193. Mallinckrodt Company Information
Table 194. Mallinckrodt Introduction and Business Overview
Table 195. Mallinckrodt Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 196. Mallinckrodt Cellular and Gene Therapy Product Product
Table 197. Mallinckrodt Recent Development
Table 198. Gilead Sciences Company Information
Table 199. Gilead Sciences Introduction and Business Overview
Table 200. Gilead Sciences Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 201. Gilead Sciences Cellular and Gene Therapy Product Product
Table 202. Gilead Sciences Recent Development
Table 203. bluebird bio Company Information
Table 204. bluebird bio Introduction and Business Overview
Table 205. bluebird bio Cellular and Gene Therapy Product Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 206. bluebird bio Cellular and Gene Therapy Product Product
Table 207. bluebird bio Recent Development
Table 208. Key Raw Materials Lists
Table 209. Raw Materials Key Suppliers Lists
Table 210. Cellular and Gene Therapy Product Market Trends
Table 211. Cellular and Gene Therapy Product Market Drivers
Table 212. Cellular and Gene Therapy Product Market Challenges
Table 213. Cellular and Gene Therapy Product Market Restraints
Table 214. Cellular and Gene Therapy Product Distributors List
Table 215. Cellular and Gene Therapy Product Downstream Customers
Table 216. Research Programs/Design for This Report
Table 217. Key Data Information from Secondary Sources
Table 218. Key Data Information from Primary Sources
List of Figures
Figure 1. Cellular and Gene Therapy Product Product Picture
Figure 2. Global Cellular and Gene Therapy Product Market Size, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global Cellular and Gene Therapy Product Market Size Status and Outlook (2018-2033) & (US$ Million)
Figure 4. Global Cellular and Gene Therapy Product Sales Status and Outlook (2018-2033) & (K Units)
Figure 5. Product Picture of Cellular Immunotherapies
Figure 6. Global Cellular Immunotherapies Sales YoY Growth (2018-2033) & (K Units)
Figure 7. Product Picture of Cancer Vaccines
Figure 8. Global Cancer Vaccines Sales YoY Growth (2018-2033) & (K Units)
Figure 9. Product Picture of Autologous and Allogeneic Cells
Figure 10. Global Autologous and Allogeneic Cells Sales YoY Growth (2018-2033) & (K Units)
Figure 11. Global Cellular and Gene Therapy Product Sales by Type (2018-2033) & (US$ Million)
Figure 12. Global Cellular and Gene Therapy Product Sales Market Share by Type in 2022 & 2033
Figure 13. North America Cellular and Gene Therapy Product Sales Market Share in Volume by Type in 2022
Figure 14. North America Cellular and Gene Therapy Product Sales Market Share in Value by Type in 2022
Figure 15. Europe Cellular and Gene Therapy Product Sales Market Share in Volume by Type in 2022
Figure 16. Europe Cellular and Gene Therapy Product Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Cellular and Gene Therapy Product Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Cellular and Gene Therapy Product Sales Market Share in Value by Type in 2022
Figure 19. Latin America Cellular and Gene Therapy Product Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Cellular and Gene Therapy Product Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Cellular and Gene Therapy Product Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Cellular and Gene Therapy Product Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Cellular and Gene Therapy Product Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Cellular and Gene Therapy Product Revenue in 2022
Figure 25. Cellular and Gene Therapy Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Blood Cancer
Figure 27. Global Blood Cancer Sales YoY Growth (2018-2033) & (K Units)
Figure 28. Product Picture of Prostate Cancer
Figure 29. Global Prostate Cancer Sales YoY Growth (2018-2033) & (K Units)
Figure 30. Product Picture of Skin Cancer
Figure 31. Global Skin Cancer Sales YoY Growth (2018-2033) & (K Units)
Figure 32. Product Picture of Other
Figure 33. Global Other Sales YoY Growth (2018-2033) & (K Units)
Figure 34. Global Cellular and Gene Therapy Product Sales by Application (2018-2033) & (US$ Million)
Figure 35. Global Cellular and Gene Therapy Product Sales Market Share by Application in 2022 & 2033
Figure 36. North America Cellular and Gene Therapy Product Sales Market Share in Volume by Application in 2022
Figure 37. North America Cellular and Gene Therapy Product Sales Market Share in Value by Application in 2022
Figure 38. Europe Cellular and Gene Therapy Product Sales Market Share in Volume by Application in 2022
Figure 39. Europe Cellular and Gene Therapy Product Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Cellular and Gene Therapy Product Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Cellular and Gene Therapy Product Sales Market Share in Value by Application in 2022
Figure 42. Latin America Cellular and Gene Therapy Product Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Cellular and Gene Therapy Product Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Cellular and Gene Therapy Product Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Cellular and Gene Therapy Product Manufacturing Cost Structure
Figure 47. Cellular and Gene Therapy Product Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed